Delays in completion and results reporting of clinical trials under the Paediatric Regulation in the European Union: A cohort study.

about

Delays in completion and results reporting of clinical trials under the Paediatric Regulation in the European Union: A cohort study.

Item

http://www.wikidata.org/entity/Q52679541

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Delays in completion and resul ...... uropean Union: A cohort study.

@en

Delays in completion and resul ...... uropean Union: A cohort study.

@nl

type

Item

label

Delays in completion and resul ...... uropean Union: A cohort study.

@en

Delays in completion and resul ...... uropean Union: A cohort study.

@nl

prefLabel

Delays in completion and resul ...... uropean Union: A cohort study.

@en

Delays in completion and resul ...... uropean Union: A cohort study.

@nl

P1476

Delays in completion and resul ...... European Union: A cohort study

@en

P2093

Thomas J Hwang

http://www.w3.org/2001/XMLSchema#string

P2860

Postapproval studies of drugs initially approved by the FDA on the basis of limited evidence: systematic review.

Pediatric versus adult drug trials for conditions with high pediatric disease burden.

A prospective questionnaire assessment of attitudes and experiences of off label prescribing among hospital based paediatricians.

Peer-reviewed publication of clinical trials completed for pediatric exclusivity

Safety and transparency of pediatric drug trials.

European Medicines Agency review of post-authorisation studies with implications for the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance.

Pediatric Medicine Development: An Overview and Comparison of Regulatory Processes in the European Union and United States.

Discontinuation and Nonpublication of Randomized Clinical Trials Conducted in Children.

Characteristics and follow-up of postmarketing studies of conditionally authorized medicines in the EU.

The characteristics and fulfillment of conditional prescription drug approvals in Canada.

P304

e1002520

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PMED.1002520

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paolo Tomasi

Florence T Bourgeois

P577

2018-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29494592

http://www.w3.org/2001/XMLSchema#string

P932

5832187

http://www.w3.org/2001/XMLSchema#string